Shafer Width and Girth: The Use of Injectable Fillers for Penile Enhancement
Not Applicable
- Conditions
- Micropenis
- Interventions
- Device: Hyaluronic Acid
- Registration Number
- NCT04755634
- Lead Sponsor
- Shafer Clinic Fifth Avenue
- Brief Summary
Injectable filler will be performed by Principal Investigator under sterile conditions for the enhancement of girth and surface area of the penis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
- Healthy males,
- 21 to 65 years of age,
- Seeking enhancement of their penile width and girth.
Exclusion Criteria
- Patient with a history of psychological or psychiatric illness,
- Congenital or acquired penile malformation,
- Previous plastic surgery or non-invasive treatments of their penis,
- Any chronic disease such as vascular disorder, urological disorder, myocardial infarction, hypertension, cerebrovascular accident or coagulopathy.
- Patients with a history of allergic reactions to hyaluronic acid derivatives
- Individuals with penises measured less than 6 cm in length in the flaccid position
- Individuals with penises greater than 12.5 cm in length in the flaccid position.
- Individuals with uncircumcised penises
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Single Arm Hyaluronic Acid This is a prospective, single-arm, single-center study
- Primary Outcome Measures
Name Time Method Increase in penile width and girth 1 year Three-dimensional (3D) surface images taken by a digital stereophotogrammetry system at the baseline will be compared to the images taken at 1 year post-treatment follow up.
- Secondary Outcome Measures
Name Time Method Duration of increase in penile width and girth 1 year For how long duration the treatment will produce a measurable difference in penile size.
Trial Locations
- Locations (1)
Shafer Clinic Fifth Avenue
🇺🇸New York, New York, United States